Natixis’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-176,700
Closed -$37.6M 493
2014
Q4
$37.6M Buy
176,700
+23,428
+15% +$4.66M 0.52% 36
2014
Q3
$27.3M Sell
153,272
-1,728
-1% -$287K 0.42% 41
2014
Q2
$26.2M Sell
155,000
-435,200
-74% -$67.8M 0.32% 78
2014
Q1
$73.2M Buy
590,200
+202,000
+52% +$24.6M 0.95% 23
2013
Q4
$43.1M Buy
+388,200
New +$37.1M 0.37% 56
2013
Q3
Sell
-240,000
Closed -$20.2M 623
2013
Q2
$20.2M Buy
+240,000
New +$24.9M 0.29% 87

Other funds holding AGN

Natixis's AGN Position: Q1 2015 in Review

Natixis sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 176,700 shares — an estimated $37.6M sold.

Natixis first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $73.2M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Natixis reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Natixis sold 176,700 Allergan Inc shares in Q1 2015, an estimated $37.6M.
  • Natixis first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Natixis's Allergan Inc position peaked at $73.2M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Natixis's 13F filing for Q1 2015, filed 22 May 2015.